Associations of subtypes of hemoglobin with delta-aminolevulinic acid dehydratase genotype and dimercaptosuccinic acid-chelatable lead levels

Archives of Environmental Health

Volumn 52, Issue 2, 1997, Pages 97-103

  Schwartz, Brian S ^a,b,c   Stewart, Walter ^a,b   Lee, Byung Kook ^d   Ahn, Kyu Dong ^d   Kelsey, Karl ^e,f   Bressler, Joseph ^b,g  

^a Occup and Environmental Medicine   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Soonchunhyang University   (South Korea)

^e MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A2; LEAD; PORPHOBILINOGEN SYNTHASE; SUCCIMER;

ARTICLE; BATTERY INDUSTRY; BINDING SITE; GENOTYPE; HEMOGLOBIN DETERMINATION; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH KOREA;

EID: 0030968006     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039899709602871     Document Type: Article

References (32)

1. DeSilva PE. Determination of lead in plasma and studies of its relationship to lead in erythrocytes. Br J Ind Med 1981; 38:209-17.
2. Manton Wl, Cook JD. High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid. Br J Ind Med 1984; 41:313-19.
3. Simons TJB. Lead transport and binding by human erythrocytes in vitro. Pfiigers Arch 1993; 423:307-13.
4. Raghavan SRV, Culver BD, Gonick HC. Erythrocyte lead-binding protein after occupational exposure. I. Relationship to lead toxicity. Environ Res 1980; 22:264-70.
5. Lolin Y, O'Gorman P. An intra-erythrocytic low molecular weight lead-binding protein in acute and chronic lead exposure and its possible protective role in lead toxicity. Ann Clin Biochem 1988; 25:688-97.
6. Ong CN, Lee WR. High affinity of lead for fetal haemoglobin. Br J Ind Med 1980; 37:292-98.
7. Bruenger FW, Steven W, Stover BJ. The association of 210Pb with constituents of erythrocytes. Health Phys 1973; 25:34-42.
8. Bunn HF. Pathophysiology of the anemias. In: Isselbacher KJ, Braunwald E, Wilson JD, et al. (Eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1994; pp 1717-21.
9. Albahary C. Lead and hemopoiesis. The mechanism and consequences of the erythropathy of occupational lead poisoning. Am J Med 1972; 52:367-78.
10. Taniguchi N, Sato T, Kondo T, et al. Carbonic anhydrase isozymes, hemoglobin-F and glutathione levels in lead-exposed workers. Clin Chim Acta 1975; 59:29-34.
11. Ziemsen B, Angerer J, Lehnert G, et al. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 1986; 58:245-47.
12. Wetmur JG, Lehnert G, Desnick RJ. The 8-aminolevulinate dehydratase polymorphism: high blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 1991; 56:109-19.
13. Schwartz BS, Lee B-K, Stewart W, et al. 8-Aminolevulinic acid dehydratase genotype modifies 4-hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med 1997 (in press).
14. Sithisarankul P, Schwartz BS, Lee B-K, et al. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers Am J Ind Med 1997 (in press).
15. Smith CM, Wang X, Hu H, et al. A Polymorphism in the 8-amino-levulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 1995; 103:248-53.
16. Schwartz BS, Lee B-K, Stewart W, et al. Associations of S-amino-levulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 1995; 142:738-45.
17. Lee B-K, Schwartz BS, Stewart W, et al. Urinary lead excretion after DMSA and EDTA: evidence for differential access to lead-storage sites. Occup Environ Med 1995; 52:13-19.
18. Brangstrup Hansen JP, Dessing M, Paulev P-E. Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man. J Occup Med 1981; 23:39-43.
19. Araki S, Aono H, Murata K. Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators. Br J Ind Med 1986; 43:636-41.
20. Tell I, Somervaille LJ, Nilsson U, et al. Chelated lead and bone lead. Scand J Work Environ Health 1992; 18:113-19.
21. Alessio L, Castoldi MR, Monelli O, et al. Indicators of internal dose in current and past exposure to lead. Int Arch Occup Environ Health 1979; 44:127-32.
22. Aposhian HV, Maiorino RM, Dart RC, et al. Urinary excretion of meso-2, 3-dimercaptosuccinic acid in human subjects. Clin Pharmacol Ther 1989; 45:520-26.
23. Huntsman RC. Red blood cell hemolysate preparation. In: Schmidt RM, Huisman THJ, Lehman H (Eds). The Detection of Hemoglobinopathies. Cleveland, OH: CRC Press, 1974; pp 4-6.
24. Reicwlli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971; 284:353-57.
25. Huisman THJ, Schroeder WA, Brodie AN, et al. Microchromatography of hemoglobins. 111. A simplified procedure for the determination of hemoglobin A2. J Lab Clin Med 1975; 86:700-02.
26. Abraham EC. Clycosalated Hemoglobins: Methods of Analysis and Clinical Applications. New York: Marcel Dekker, 1985.
27. Bunn HF, Haney DN, Kamin S, et al. The biosynthesis of human hemoglobin A]c. J Clin Invest 1976; 57:1652-59.
28. Bunn HF, Forget BC. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, PA: WB Saunders, 1986.
29. Raghavan SRV, Culver BD, Conick HC, Erythrocyte lead-binding protein after occupational exposure. II. Influence on lead inhibition of membrane Na+, K+-adenosinetriphosphatase. J Toxicol Environ Health 1981; 7:561-68.
30. Sugawara E, Nakamura K, Miyaka T, et al. Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br J Ind Med 1991; 48:239-42.
31. Grandjean P, Jensen BM, Sando SH, et al. Delayed blood regeneration in lead exposure: an effect on reserve capacity. Am J Public Health 1989; 79:1385-88.
32. Cory-Slechta DA. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J Pharmacol Exp Ther 1988; 246:84-91.